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Introduction CC screening 
(small scale)
Crystal Structures
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“Drug-drug” cocrystals (CC) are part of pharmaceutical cocrystals
(PCC) wherein two costitutive components (drug and coformer)
represent Active Pharmaceutical Ingredients (APIs) cocrystallized in
stoichiometric ration into crystalline single phase. “Drug-drug”
represent multicomponent complexes where the Charge Transfer
(CT) or Electron Donor-Acceptor (EDA) Interactions between two
APIs molecules may determine their crystal packing motifs that in first
line exert dual or complementry pharmacological effect and alter the
drug’s physicochemical properties (e.g. solubility, melting point etc.)
which directly affect its biopharmaceutical profile (e.g. drug
dissolution, absorption) and processability of its solid phase (e.g.
hygroscopicity, compressibility) [1-4].
“Drug-drug” CCs offer opportunities for formulations fixed-doses drug
delivery systems including one API substance in form of “drug-drug”
CC as New Chemical Entity (NCE)to obtain dual effect in therapy.
First Drug model (DM) Metformin (MET), N,N-dimethylbiguanide is
the only approved hypoglycemic drug of the biguanide classis used
as oral type 2 diabetes, marketed as hydrochloride, embonat
(pamoate) and p-chlorophenoxy acetate salt [5].
Because of the biguanide π-conjugated system, MET in solution can
exist in three resonance-stabilized forms, i.e. as neutral molecule
(MET), monoprotonated (METH+) or diprotonated (METH2+) cation,
with dissociation constants in water typical of biguanides:
Metformin = L; [HL]/[L][H] pKa1(N−H
+)~12.40;
[H2L]/[HL][H] pKa2(N−H
+)= 2.96 (NIST database)
The high basicity of pKa1 and the difference between the pKa values
qualify MET as organosuperbase and determine the stability of its
monoprotonated form METH+ within a wide range of pH [2].
Drug models used as CFs are:
Dichloroacetic acid Dichloroacetate (DCA) was introduced as novel
class of oral ant diabetic drug that reduce blood glucose and lipids
without stimulating insulin secretion. Recent study reveled its
anticancer effect [6].
Diclofenac and salicylic acid are widely used anti-inflammatory drugs
in pain-killer therapy.
Glycolic acid is drug applied for acne treatment in dermatology, as
well it is a strong enhancer for drug transdermal delivery [7].
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Single crystals with quality for structure
determination were obtained by slow controlled
rate of solvent evaporation techniques.
Crystal structure were determined by single X-ray 
diffraction analyses. For quality control of the prepared 
large scaled batches, X-Ray powder diffraction (XRPD) and 
FT-IR Spectroscopy were applied. Thermodynamic 
properties were tested on Different Scanning Calorimetry
(DSC)
Characterization of PCC 
2.808
2.950
Further Work
Metformin salicylate 1:1 MMMetformin acetate 1: 1
Metformin glycolate 1:1
P 21/n
P 21/n
MET dichloroacetate 1:1 
MET dichloroacetate  1:2
2.909
2.970
P21/n
2.836
2.912
P-1
MET diclofenac 1:1
P21/c
Method of preparation 
(Large scale )
Crystalline 
solid
MET∙HCl
Dissolved in methanol
Suspended in
isopropanol,  
DCAA∙Na
MET dichloroacetate 1:1
Crystalline solid
The same method was applied for preparation of
MET Dichloroacetic acid 1:2; MET:Diclofenac 1:1; and
MET glycolate
DM I
DM II
(CF)
pKa 
(CF)
Molar
ratio
Slow-rate 
solvent
evaporation
(SRSE)
“drug-drug” CCs
Metformin 
neutralized
(MET)
pKa1 : 12.4
pKa2 : 2.96
Acetic acid 4.75 1:1 methanol, SRSE
MET acetate 
1:1
Dichloracetic 
acid
1.1
1:1 & 
1:2
methanol /n-
pentanol
50/50 V/V %
MET
dichloroacetate 
1:1 & 1:2
Diclofenac 3.99 1:1
methanol /n-
pentanol
50/50 V/V %
MET Diclofenac
1:1
Glycolic acid 3.83 1:1
methanol /n-
pentanol
50/50 V/V %
MET glycolate
1:1
Metformin∙HCl
Dichloroacetate
Sodium 
(DCAA∙Na)
1.1 1:1
Kneaded in n-
pentanol, filtrated, 
clear solution 
MET
dichloroacetate 
1:1 
Diclofenac 
Sodium
3.99 1:1
Kneaded in 
ethanol: sediment 
re-suspended in n-
pentanol, filtrated, 
clear solution 
MET diclofenac
1:1
P-1
Filtered 
(remove NaCl)
Clear solution
rotoevaporated 
Kept steering 12 h
rotoevaporated
MET dichloroacetate 1:1, lot I
MET dichloroacetate 1:1, lot I
Dichloroacetate  Na
Metformin HCl
MET dichloroacetate 1:2
Dichloroacetate  Na
Metformin HCl
FTIR
MET Diclofenac 1:1, lot III 
Diclofenac Na
Metformin HCl
Operations: Import
File: Metformin Dichloroacetic acid, 1 1 molar ratio, sample 2.raw - Type: 2Th/Th locked - Step: 0.020 ° - Step time: 2. s - Anode: Cu - WL1: 1.5406 - Company:  Uni Ferrara
Operations: Import
File: Metformin Dichloroacetic acid, 1 1 molar ratio, calculated.raw - Type: 2Th/Th locked - Step: 0.020 ° - Step time: 0.1 s - WL1: 1.5406 - Company: Exported by CCDC-toolkit
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Operations: Import
File: Metformin Dichloroacetic acid, 1 2 molar ratio sample.raw - Type: 2Th/Th locked - Step: 0.020 ° - Step time: 2. s - Anode: Cu - WL1: 1.5406 - Company:  Uni Ferrara
Operations: Import
File: Metformin Dichloroacetic acid, 1 2 molar ratio, calculated.raw - Type: 2Th/Th locked - Step: 0.020 ° - Step time: 0.1 s - WL1: 1.5406 - Company: Exported by CCDC-toolkit
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Operations: Import
File: Metformin Diclofenac 1 1 molar ratio, sample 9A.raw - Type: Locked Coupled - Step: 0.020 ° - Step time: 2. s - Anode: Cu - WL1: 1.5406 - Company:  Uni Ferrara
Operations: Import
File: Metformin Diclofenac, 1 1 molar ratio, calculated.raw - Type: 2Th/Th locked - Step: 0.020 ° - Step time: 0.1 s - WL1: 1.5406 - Company: Exported by CCDC-toolkit
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Measurements for equilibrium solubility and dissolution profiles are 
upcoming in order entire solid state profile to “drug-drug” CCs to be 
resolved.  
